Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 22, 2004
Somatostatin receptors in malignant lymphomas: targets for radiotherapy?Virgil A S H Dalm, Leo J Hofland, Cornelia M Mooy, et al.
American Journal of Physiology. Endocrinology and Metabolism|March 17, 2005
Distinct functional properties of native somatostatin receptor subtype 5 compared with subtype 2 in the regulation of ACTH release by corticotroph tumor cellsJoost van der Hoek, Marlijn Waaijers, Peter M van Koetsveld, et al.
Neuroendocrinology|February 3, 2016
Effects of Somatostatin Analogs and Dopamine Agonists on Insulin-Like Growth Factor 2-Induced Insulin Receptor Isoform A Activation by Gastroenteropancreatic Neuroendocrine Tumor CellsRoxanne C S van Adrichem, Wouter W de Herder, Kimberly Kamp, et al.
The Journal of Clinical Endocrinology and Metabolism|September 10, 2004
Dopamine receptor expression and function in human normal adrenal gland and adrenal tumorsRosario Pivonello, Diego Ferone, Wouter W de Herder, et al.
Annals of Surgery|August 2, 2007
Type I interferons in the treatment of pancreatic cancer: mechanisms of action and role of related receptorsGiovanni Vitale, Casper H J van Eijck, Peter M van Koetsveld Ing, et al.
European Journal of Endocrinology|July 27, 2022
Digital quantification of somatostatin receptor subtype 2a immunostaining: a validation studyClaudia Campana, Peter M van Koetsveld, Richard A Feelders, et al.
The Journal of Clinical Endocrinology and Metabolism|January 10, 2003
Luteinizing hormone (LH)-responsive Cushing's syndrome: the demonstration of LH receptor messenger ribonucleic acid in hyperplastic adrenal cells, which respond to chorionic gonadotropin and serotonin agonists in vitroRichard A Feelders, Steven W J Lamberts, Leo J Hofland, et al.
The Journal of Clinical Endocrinology and Metabolism|August 17, 2006
Potent inhibitory effects of type I interferons on human adrenocortical carcinoma cell growthPeter M van Koetsveld, Giovanni Vitale, Wouter W de Herder, et al.
Endocrinology|October 31, 2013
β-Arrestin 1 and 2 and G protein-coupled receptor kinase 2 expression in pituitary adenomas: role in the regulation of response to somatostatin analogue treatment in patients with acromegalyFederico Gatto, Richard Feelders, Rob van der Pas, et al.
Endocrine-Related Cancer|May 30, 2008
Efficacy of a dopamine-somatostatin chimeric molecule, BIM-23A760, in the control of cell growth from primary cultures of human non-functioning pituitary adenomas: a multi-center studyTullio Florio, Federica Barbieri, Renato Spaziante, et al.
Pageof 7